ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR
Publication
, Conference
Thompson, AJ; Santoro, R; Piazzolla, V; Tillman, HL; Patel, K; Clark, PJ; Naggie, S; Shianna, K; Mottola, L; Petruzzellis, D; Romano, M ...
Published in: HEPATOLOGY
October 1, 2010
Duke Scholars
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2010
Volume
52
Issue
4
Start / End Page
785A / 786A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Thompson, A. J., Santoro, R., Piazzolla, V., Tillman, H. L., Patel, K., Clark, P. J., … Mangia, A. (2010). ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR. In HEPATOLOGY (Vol. 52, pp. 785A-786A). Boston, MA: WILEY-BLACKWELL.
Thompson, Alexander J., Rosanna Santoro, Valeria Piazzolla, Hans L. Tillman, Keyur Patel, Paul J. Clark, Susanna Naggie, et al. “ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR.” In HEPATOLOGY, 52:785A-786A. WILEY-BLACKWELL, 2010.
Thompson AJ, Santoro R, Piazzolla V, Tillman HL, Patel K, Clark PJ, et al. ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR. In: HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 785A-786A.
Thompson, Alexander J., et al. “ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR.” HEPATOLOGY, vol. 52, no. 4, WILEY-BLACKWELL, 2010, pp. 785A-786A.
Thompson AJ, Santoro R, Piazzolla V, Tillman HL, Patel K, Clark PJ, Naggie S, Shianna K, Mottola L, Petruzzellis D, Romano M, Sogari F, Facciorusso D, Goldstein DB, McHutchison JG, Mangia A. ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR. HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 785A-786A.
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2010
Volume
52
Issue
4
Start / End Page
785A / 786A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics